Sign in

Myeloproliferative neoplasms trials, also abroad

239 open Myeloproliferative neoplasms trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States118
Italy42
France40
China30
Germany28
Spain28
Canada21
United Kingdom21
Australia20
Poland16
Belgium15
Netherlands13
Japan11
Austria10
Czechia10
Hungary10
South Korea10
Romania8
Bulgaria7
Greece7
Israel6
Türkiye6
Brazil5
Taiwan5
Denmark4
Malaysia4
New Zealand4
Puerto Rico4
Portugal4
Argentina3
Switzerland3
Hong Kong3
Mexico3
Russia3
Saudi Arabia3
Georgia2
Ireland2
India2
Lebanon2
Norway2
Serbia2
Sweden2
Singapore2
Thailand2
Vietnam2
Armenia1
Chile1
Colombia1
Oman1
Slovakia1
Tunisia1
Uzbekistan1

The same trial often runs in several countries

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib has 7 sites in Croatia and runs in 19 countries. If a site near you is full, another one may still take people.

See Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib in all 19 countries